← Leaderboards
Xiang Gao
Oncotrap, Inc.
$1,060,528
Attributed
$1,060,528
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $761.4K · FY2022–23$1M$750K$500K$250K$0
'22
'23
Funding mix
By agency
NIH$1,060,528 · 3
By mechanism
R43$1,060,528 · 3
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Binding”
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Heinz Ernst Moser · University Of Texas Med Br Galveston$12,973,432
- Jason Dickens · Duke University$12,259,409
- Colin Osborne · University Of Texas Med Br Galveston$10,407,745
- Jeff T Hutchins · Inhalon Biopharma, Inc.$9,139,075
- Joseph Fraser Glickman · Hackensack University Medical Center$8,363,749
Research focus
BindingSpecificityIn VitroMouse ModelIn VivoSmall Business Innovation Research GrantPhase 2 StudySurfaceMediatingInnovationLeadMedicalAffinityLiverEnsureDosageExperimental StudyCell ProliferationCytokineDirected Molecular EvolutionAntibodiesEngineeringAnimalsChemokine
Grant awards (3)
An Aptamer-directed IgG1-Fc Drug Conjugate (AFDC) for Treating Pancreatic Cancer$400,000
R43 · FY2023 · CA · contact PI
Development of A Dual Chemokine CCL2/CCL5 Neutralizing Single-domainAntibody for Treating Non-alcoholic Steatohepatitis$361,400
R43 · FY2023 · DK · contact PI
mRNA Delivery of a Panel of Single-Domain Antibodies for Combinatorial Deciphering of Therapeutic Targets for Covid-19 Related Cytokine Release Syndrome$299,128
R43 · FY2022 · AI · contact PI